Chemours
506 hedge funds and large institutions have $3.79B invested in Chemours in 2018 Q4 according to their latest regulatory filings, with 87 funds opening new positions, 137 increasing their positions, 173 reducing their positions, and 128 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
506
Holders Change
-45
Holders Change %
-8.17%
% of All Funds
11.29%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.2%
New
87
Increased
137
Reduced
173
Closed
128
Calls
$26.4M
Puts
$18.8M
Net Calls
+$7.62M
Net Calls Change
+$45.4M
Top Buyers
| 1 |
TCIM
TIAA CREF Investment Management
New York
|
+$55.9M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$50M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
+$31.7M |
| 4 |
Bank of New York Mellon
New York
|
+$24.3M |
| 5 |
LM
Luminus Management
Houston,
Texas
|
+$21.4M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$56.9M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$55.1M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
-$43.1M |
| 4 |
AAM
Ardevora Asset Management
London,
United Kingdom
|
-$35.5M |
| 5 |
GCM
Gates Capital Management
New York
|
-$28.9M |
